Both in Pharmaceuticals
Veradermics, Incorporated vs PTC Therapeutics
Over the past year MANE returned +251.3% and PTCT returned −6.1%; their daily moves had a correlation of 0.19.
MANE +251.3% PTCT −6.1%Growth of $1, one year, split-adjusted
| Metric | MANE | PTCT |
|---|---|---|
| Price | $133.61 | $68.12 |
| Market cap | $5.58B | $5.69B |
| Today | +3.15% | +11.89% |
| 1 month | +12.4% | +7.0% |
| 6 months | +16.4% | +4.7% |
| Year to date | — | −10.3% |
| 1 year | — | −0.3% |
| Revenue growth (YoY) | — | +69.6% |
| Gross margin | — | 93.4% |
| Net margin | — | −14.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.9× |
| Net cash | $819.9M | $1.59B |
| Dividend yield | — | — |
| Volatility (60d) | 63.8% | 43.4% |
| Short % of float | 15.2% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).